Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Not yet recruiting × NETWORK × Dasatinib × Clear all

Phase

Status

Completed 3 Active not recruiting 2 Unknown 1 Terminated 1 Recruiting 1 Not yet recruiting 1

Sponsor Class

OTHER 1 NETWORK 1

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Multiple Myeloma 1

Interventions

Specimen Handling 5 Magnetic Resonance Spectroscopy 4 Standard of Care 3 Practice Guidelines as Topic 3 Cyclophosphamide 3 Biopsy 3 Radiotherapy 2 zanubrutinib 1 talquetamab 1 sulforaphane 1 sacituzumab govitecan 1 liposomal doxorubicin 1 fludarabine 1 daratumumab 1 asciminib 1 X-Rays 1 Vinorelbine 1 Vincristine 1 Stem Cell Transplantation 1 Spinal Puncture 1 Sentinel Lymph Node Biopsy 1 Radiation 1 Propranolol 1 Pluvicto 1 Pharmaceutical Preparations 1 Paclitaxel 1 Methods 1 Lidocaine 1 Leukapheresis 1 Irinotecan 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT05944783 2025-02-12

BE-Dasatinib

Centro de Atencion e Investigacion Medica

Phase 4 Not yet recruiting

Multiple Myeloma

Data powered by HemOnc (CC BY 4.0) Colophon ⚡